CSL Ltd (ASX:CSL)
A$ 283.99 -2.35 (-0.82%) Market Cap: 137.51 Bil Enterprise Value: 153.48 Bil PE Ratio: 35.09 PB Ratio: 5.29 GF Score: 97/100

Half Year 2020 CSL Ltd Earnings Presentation Transcript

Feb 12, 2020 / 12:00AM GMT
Release Date Price: A$328.25 (+0.77%)

Feb 12, 2020 / 12:00AM GMT
Presentation
Feb 12, 2020 / 12:00AM GMT

=====================
Corporate Participants
=====================
* David Mark Lamont
CSL Limited - CFO
* Mark Dehring
CSL Limited - Head of IR
* Paul R. Perreault
CSL Limited - MD, CEO & Executive Director

=====================
Conference Call Participants
=====================
* Andrew Goodsall
MST Marquee - Healthcare analyst
* Chris Cooper
Goldman Sachs Group Inc., Research Division - Research Analyst
* David A. Low
JP Morgan Chase & Co, Research Division - Research Analyst
* David Andrew Stanton
Jefferies LLC, Research Division - Equity Analyst
* David Bailey
Macquarie Research - Research Analyst
* Gretel Janu
Crédit Suisse AG, Research Division - Research Analyst
* John Deakin-Bell
Citigroup Inc, Research Division - Director & Head of Healthcare in Australia and New Zealand
* Lyanne Harrison
BofA Merrill Lynch, Research Division - VP
* Saul

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot